Fundraising FoxLuma Group — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Ken Drazan(Founder)James Ahlers(Executive Officer)Irene Pleasure(Executive Officer)Margaret Nibbi(Executive Officer)Alexander Marson(Founder)Kole Roybal(Founder)
Co-investorsARCH Venture PartnersHitachi VenturesKleiner PerkinsOUP (Osage University Partners)SoftBank Vision FundWestlake Village BioPartners+4 more
Curve Bio builds Whole-Body Intelligence models from its Whole-Body Atlas, a molecular map of the body, to power blood tests that monitor organ health in chronic disease patients.
AI & Machine LearningBiotechDigital HealthDallas, US
Nathan Hunkapiller(Founder)inProf. Shan Wang, PhD(Chief Innovation Officer and Scientific Founder)Ritish Patnaik, PhD(Chief Executive Officer)CHUBA OYOLU(Executive Officer)SHAN XIANG WANG(Executive Officer, Director)RITISH PATNAIK(Executive Officer, Director)
Co-investorsFirst Spark Ventures, LlcLifeX VenturesNZVCCivilization Ventures Management, LlcMintaka
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.